Factors associated with herpes zoster vaccination status and acceptance of vaccine recommendation in community pharmacies

Vaccine

Volumn 32, Issue 43, 2014, Pages 5749-5754

  Teeter, Benjamin S ^a   Garza, Kimberly B ^a   Stevenson, T Lynn ^a   Williamson, Margaret A ^a   Zeek, Megan L ^a   Westrick, Salisa C ^a  

^a AUBURN UNIVERSITY   (United States)

Author keywords

Education; Herpes zoster; Pharmacy; Shingles; Vaccination; Zostavax

Indexed keywords

VARICELLA ZOSTER VACCINE;

ADULT; AGED; ARTICLE; ATTITUDE TO HEALTH; AWARENESS; CAUCASIAN; CROSS-SECTIONAL STUDY; FEMALE; HEALTH CARE PERSONNEL; HERPES ZOSTER; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PATIENT ATTITUDE; PATIENT EDUCATION; PHARMACIST; PHARMACY; SELF REPORT; UNITED STATES; VACCINATION; CLINICAL TRIAL; HEALTH PROMOTION; INTERVENTION STUDY; MIDDLE AGED; PHARMACY STUDENT; PROCEDURES; QUESTIONNAIRE; STATISTICS AND NUMERICAL DATA;

AGED; ALABAMA; COMMUNITY PHARMACY SERVICES; CROSS-SECTIONAL STUDIES; FEMALE; FLORIDA; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HEALTH PROMOTION; HERPES ZOSTER; HERPES ZOSTER VACCINE; HUMANS; INTERVENTION STUDIES; MALE; MIDDLE AGED; PATIENT ACCEPTANCE OF HEALTH CARE; PATIENT EDUCATION AS TOPIC; QUESTIONNAIRES; STUDENTS, PHARMACY; VACCINATION;

EID: 84908458658     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2014.08.040     Document Type: Article

References (23)

1. Harpaz R., Ortega-Sanchez I.R., Seward J.F. Prevention of herpes zoster: recommendations of the advisory committee on immunization practices (acip). MMWR Recomm Rep 2008, 57(RR-5):1-30.
2. Soni A., Hill S.C. Average health care use and expenses for Shingles among the U.S. Civilian noninstitutionalized population. Statistical brief #194 2003-2005, Agency for Healthcare Research and Quality, Rockville, MD.
3. Rothberg M.B., Virapongse A., Smith K.J. Cost-effectiveness of a vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. Clin Infect Dis 2007, 44(10):1280-1288.
4. Centers for Disease Control and Prevention Noninfluenza vaccination coverage among adults-United States, 2011. MMWR morbidity and mortality weekly report 2013, vol. 62:66-72. Centers for Disease Control and Prevention, Washington, DC.
5. Lu P., Euler G., Jumaan A., Harpaz R. Herpes zoster vaccination among adults aged 60 years or older in the united states, 2007: uptake of the first new vaccine to target seniors. Vaccine 2009, 27(6):882-887.
6. Joon Lee T., Hayes S., Cummings D.M., Cao Q., Carpenter K., Heim L., Edwards H. Herpes zoster knowledge, prevalence, and vaccination rate by race. J Am Board Fam Med 2013, 26(1):45-51.
7. Lu P.J., Euler G.L., Harpaz R. Herpes zoster vaccination among adults aged 60 years and older, in the U.S., 2008. Am J Prev Med 2011, 40(2):e1-e6.
8. Hurley L.P., Lindley M.C., Harpaz R., Stokley S., Daley M.F., Crane L.A., et al. Barriers to the use of herpes zoster vaccine. Ann Intern Med 2010, 152(9):555-560.
9. Jung J.J., Elkin Z.P., Li X., Goldberg J.D., Edell A.R., Cohen M.N., et al. Increasing use of the vaccine against zoster through recommendation and administration by ophthalmologists at a city hospital. Am J Ophthalmol 2013, 155(5):787-795.
10. Hurley L.P., Harpaz R., Daley M.F., Crane L.A., Beaty B.L., Barrow J., et al. National survey of primary care physicians regarding herpes zoster and the herpes zoster vaccine. J Infect Dis 2008, 197(Suppl 2):S216-S223.
11. Campos-Outcalt D., Jeffcott-Pera M., Carter-Smith P., Schoof B.K., Young H.F. Vaccines provided by family physicians. Ann Fam Med 2010, 8(6):507-510.
12. Wood H.M., McDonough R.P., Doucette W.R. Retrospective financial analysis of a herpes zoster vaccination program from an independent community pharmacy perspective. J Am Pharm Assoc 2009, 49(1):12-17.
13. Wang J., Ford L.J., Wingate L., Uroza S.F., Jaber N., Smith C.T., et al. Effect of pharmacist intervention on herpes zoster vaccination in community pharmacies. J Am Pharm Assoc 2013, 53(1):46-53.
14. Bryan A.R., Liu Y., Kuehl P.G. Advocating zoster vaccination in a community pharmacy through use of personal selling. J Am Pharm Assoc 2013, 53(1):70-77.
15. Otsuka S.H., Tayal N.H., Porter K., Embi P.J., Beatty S.J. Improving herpes zoster vaccination rates through use of a clinical pharmacist and a personal health record. Am J Med 2013, 126(9):832.e1-832.e6.
16. Institute of Medicine (U.S.) Committee on leading health indicators for healthy people 2020.: leading health indicators for healthy people 2020: letter report 2011, National Academies Press, Washington, DC.
17. Centers for Disease Control and Prevention Vaccine information statement: shingles vaccine 2009, Centers for Disease Control and Prevention.
18. High K.P. Overcoming barriers to adult immunization. J Am Osteopath Assoc 2009, 109(6 Suppl 2):S25-S28.
19. Javed S., Javed F., Mays R.M., Tyring S.K. Herpes zoster vaccine awareness among people ≥50 years of age and its implications on immunization. Dermatol Online J 2012, 18(8). http://escholarship.org/uc/item/9n03w07g.
20. Janz N.K., Becker M.H. The health belief model: a decade later. Health Educ Q 1984, 11(1):1-47.
21. Webb T.L., Sheeran P. Does changing behavioral intentions engender behavior change?. A meta-analysis of the experimental evidence. Psychol Bull 2006, 132(2):249.
22. Ajzen I. From intentions to actions: a theory of planned behavior. Action Control 1985, 11-39. Springer Berlin Heidelberg.
23. Fisher W.A., Kohut T., Salisbury C.M.A., Salvadori M.I. Understanding human papillomavirus vaccination intentions: comparative utility of the theory of reasoned action and the theory of planned behavior in vaccine target age women and men. J Sex Med 2013, 10(10):2455-2464.